Concepedia

Vaccination of patients with cutaneous melanoma with telomerase-specific peptides

Robert E. Hunger, Kristin Lang, Carrie J. Markowski, Sissel Trachsel, Mona Møller, Jon Amund Eriksen, Anne‐Marie Rasmussen, Lasse R. Braathen, Gustav Gaudernack

Cancer Immunology Immunotherapy · 2011 · 48 citations · 20 references

DOIFull text

Open access

Concepts

References

20

CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells

Sergio A. Quezada · Journal of Clinical Investigation · 2006 · 690 citations · Full text

, , +17

The Telomerase Catalytic Subunit Is a Widely Expressed Tumor-Associated Antigen Recognized by Cytotoxic T Lymphocytes

Robert H. Vonderheide, William C. Hahn, Joachim L. Schultze et al. · Immunity · 1999 · 567 citations · Full text

, , +16

Clinical and Immunologic Results of a Randomized Phase II Trial of Vaccination Using Four Melanoma Peptides Either Administered in Granulocyte-Macrophage Colony-Stimulating Factor in Adjuvant or Pulsed on Dendritic Cells

Craig L. Slingluff, Gina R. Petroni, Galina V. Yamshchikov et al. · Journal of Clinical Oncology · 2003 · 321 citations

, , +17

Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: a dose escalating phase I/II study

Stephan Bernhardt, Dagmar S. Trachsel, Mona Møller et al. · British Journal of Cancer · 2006 · 299 citations · Full text

, , +17

Intradermal ras peptide vaccination with granulocyte-macrophage colony-stimulating factor as adjuvant: Clinical and immunological responses in patients with pancreatic adenocarcinoma

Trond Buanes, Arne R. Rosseland, Arne Bakka et al. · International Journal of Cancer · 2001 · 274 citations · Full text

, , +17